Prihlásiť sa Zaregistrujte sa zadarmo

Vydané akcie spoločnosti Abcam plc

Aká je hodnota metriky Vydané akcie spoločnosti Abcam plc?

Hodnota metriky Vydané akcie spoločnosti Abcam plc je 229.272M

Aká je definícia metriky Vydané akcie?



Vydané akcie (Shares outstanding) je počet všetkých akcií spoločnosti alebo finančných aktív, ktoré boli autorizované, vydané a kúpené investormi a sú nimi vlastnené.

Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.

Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.

Vydané akcie spoločností v sektore Health Care sektor na LSE v porovnaní so spoločnosťou Abcam plc

Čomu sa venuje spoločnosť Abcam plc?

Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Europe, the Middle East, Africa, and rest of Asia Pacific. The company offers various research products, including primary and secondary antibodies; ELISA and matched antibody pairs; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; cell line and lysates; and multiplex assays. Its research products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. Further, the company offers diagnostic and therapeutic solutions. It also sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

Firmy s metrikou vydané akcie podobnou spoločnosti Abcam plc